DayMark Wealth Partners Reduces Stake in Johnson & Johnson in Latest 13F Filing

DayMark Wealth Partners Reduces Stake in Johnson & Johnson in Latest 13F Filing

DayMark Wealth Partners, LLC recently disclosed its latest 13F filing with the SEC, revealing a reduction in its position in Johnson & Johnson (NYSE: JNJ). The firm sold 618 shares of the medical biology giant, maintaining its portfolio allocation to JNJ at 2.01%.

Details of the Trade

According to the filing, DayMark Wealth Partners now holds a position in Johnson & Johnson valued at approximately $46.69 million. Despite the sale, the percentage change in the position size remained flat at 0.0%, indicating a relatively minor adjustment to its holdings. The firm’s ownership accounts for 0.01% of Johnson & Johnson’s total outstanding shares, reflecting its continued confidence in the company's long-term prospects within the medical biology sector.

Why is DayMark Wealth Partners Adjusting its Position in JNJ?

Investors may wonder about the rationale behind this adjustment. Portfolio rebalancing is a common practice among institutional investors to optimize risk and returns. Johnson & Johnson, a leader in the medical biology industry, remains a core holding for DayMark Wealth Partners, but the slight reduction could signify profit-taking or a strategic reallocation to other opportunities.

How Much of Johnson & Johnson Does DayMark Wealth Partners Own?

As of this filing, DayMark Wealth Partners owns 0.01% of Johnson & Johnson’s total shares outstanding. This stake underscores the firm’s significant, albeit slightly reduced, confidence in the company’s performance and industry leadership.

Portfolio Implications

Johnson & Johnson represents 2.01% of DayMark Wealth Partners’ overall portfolio, making it a notable holding. The decision to sell a small number of shares does not significantly alter the fund’s exposure to the healthcare sector but could reflect broader strategic considerations.

For a complete breakdown of DayMark Wealth Partners, LLC’s real-time portfolio and historical 13F data, view their profile here.